Nomenclature
CAS number: 21434-91-3
6-[(3,4,5-Trimethoxybenzoyl)amino]hexanoic acid; 6-(3,4,5-trimethoxybenzamido)hexanoic acid; 3,4,5-trimethoxybenzoyl-ε-aminocaproic acid; ATBAC; TB-ACA; C-3.
C
16H
23NO
6; mol wt 325.36.
C 59.06%, H 7.13%, N 4.30%, O 29.50%.
Description and references
Prepn: A. Garzia, DE 2034192; idem, US 3697563 (1971, 1972 both to Ist. Chemioter. Ital.); Bottazzi et al., Riv. Farmacol. Ter. 11, 215 (1971). Pharmacology: Razzaboni et al., Boll. Soc. Ital. Biol. Sper. 44, 1783 (1968). Pharmacology, metabolism and clinical
investigation of sodium salt: Greggia et al., ibid. 45, 1447 (1969); Fontanini et al., Minerva Med. 60, 4857 (1969); several authors, Riv.
Farmacol. Ter. 1 (1970); 2 (1971); 3 (1972).
Properties
White, odorless powder, mp 121-123°. uv max (ethanol):
214, 259 nm. Sol in ethanol, acetone,
chloroform, alkaline solns. Practically insol in water, ether, carbon
tetrachloride. LD50 i.p. in rats: 2.5 g/kg (Garzia, 1971).Derivative
Sodium salt.
Nomenclature
CAS number: 27276-25-1
Sodium capobenate; Capben (Schwarz).
C
16H
22NNaO
6; mol wt 347.34.
C 55.33%, H 6.38%, N 4.03%, Na 6.62%, O 27.64%.
Therapeutic Category
Antiarrhythmic (cardiac depressant).
Keywords
Antiarrhythmic
Status
This monograph has been retired and is no longer subject
to revision or update.